SCHEDULE 13D/AAccepted Mar 24, 4:15 PM ET
REVIVA PHARMACEUTICALS HOLDINGS, INC. SCHEDULE 13D/A
Accepted (ET)
4:15 PM
Mar 24, 2026
Filed
Mar 24, 2026
Documents
1
Size
9.6 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.